The uterine vasculature of women and sheep predominantly expresses type 2 A
NG II receptors that do not mediate vasoconstriction. Although systemic ANG
II infusions increase uterine vascular resistance (UVR), this could reflec
t indirect mechanisms. Thus we compared systemic and local intra-arterial A
NG II infusions in six near-term pregnant and five ovariectomized nonpregna
nt ewes to determine how ANG II increases UVR. Systemic ANG II dose-depende
ntly (P > 0.001) increased arterial:pressure (MAP) and UVR and decreased ut
erine blood,flow (UBF) in pregnant and nonpregnant ewes; however, nonpregna
nt responses exceeded pregnant (P < 0.001). In contrast, local ANG II infus
ions at rates designed to achieve concentrations in the uterine circulation
comparable to those seen during systemic infusions did not significantly d
ecrease UBF in either group, and changes in MAP and UVR were absent or mark
edly attenuated. When MAP rose during local ANG II, which only occurred wit
h doses greater than or equal to 2 ng/ml, increases in MAP were delayed mor
e than twofold compared with responses during systemic ANG II infusions and
always preceded decreases in UBF, resembling that observed during systemic
ANG II infusions. These observations demonstrate attenuated uterine vascul
ar responses to systemic ANG II during pregnancy and suggest that systemic
ANG II may increase UVR through release of another potent vasoconstrictor(s
) into the systemic circulation.